跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
microglia cell therapy
首页
药物
microglia cell therapy
microglia cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
BONE MARROW MICROGLIA PROGENITOR CELLS AND USES THEREOF
申请人: STROMINNATE THERAPEUTICS AB
优先权: 2019
EP
US
WO
4 件公开
Method for treating glioblastomas and other tumors
申请人: THE FEINSTEIN INST MEDICAL RES
优先权: 2014
US
2 件公开
METHODS AND COMPOSITIONS FOR TREATING PROGRANULIN DEFICIENCIES USING iPSC-DERIVED CELLS
申请人: BLUEROCK THERAPEUTICS LP
优先权: 2024
WO
Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis
申请人: YEDA RES & DEV
优先权: 2005
US
一种基因、融合蛋白、重组载体、重组细胞、脑靶向外泌体及其应用
申请人: 贵州医科大学
优先权: 2025
CN
Inflammation-targeted immunoregulation hydrogel microspheres as well as preparation method and application thereof
申请人: RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL MEDICINE
优先权: 2025
CN
Use of Triperugium wilfordii monomeric compound for increasing gene expression efficiency mediated by adeno-associated virus vector and subsidiarily treating neurodegenerative disease
申请人: UNIV CAPITAL MEDICAL
优先权: 2008
CN
Acoustic-magnetic response nanoparticles camouflaged by microglial cell membrane as well as preparation method and application of acoustical-magnetic response nanoparticles
申请人: FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIV
优先权: 2024
CN
药物
反馈